Tag: blood transfusion diagnostics industry trends

  • Blood Transfusion Diagnostics Market Growth Potential: What The Latest Forecast Reveals

    Blood Transfusion Diagnostics Market Growth Potential: What The Latest Forecast Reveals

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Blood Transfusion Diagnostics Market Size, Value And Growth Trajectory Through 2030

    The blood transfusion diagnostics market size has shown significant growth in recent years. It is projected to expand from $4.96 billion in 2025 to $5.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. This historical growth can be ascribed to factors such as the limited availability of advanced blood diagnostics instruments, reliance on manual blood grouping methods, an increase in hospital blood transfusion procedures, the growing prevalence of transfusion-transmissible infections, and a lack of standardized reagents and kits.

    The blood transfusion diagnostics market is anticipated to experience substantial growth in the coming years. It is projected to expand to $6.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected growth can be attributed to several factors, including the advancement of high-throughput automated blood screening systems, a rising demand for nucleic acid amplification and rapid tests, increased investment in blood banks and diagnostic laboratories, the integration of digital and AI-enabled diagnostic solutions, and the expansion of plasma fractionation and research endeavors. Significant trends expected during this period include an elevated demand for rapid and accurate blood typing, the growing adoption of automated blood processing systems, an expansion of disease screening capabilities, the growth of plasma fractionation and diagnostic laboratories, and an enhanced focus on standardization and quality control.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=33783176&type=smp&name=Blood%20Transfusion%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

    Blood Transfusion Diagnostics Market Industry Drivers: What’s Behind The Revenue Growth?

    The expansion of the blood transfusion diagnostics market is anticipated due to the growing volume of surgical interventions. Surgical procedures involve medical operations conducted to address injuries, diseases, or various disorders through either manual or instrumental methods. A rise in global surgical activity directly leads to a greater demand for secure and compatible blood transfusions, essential for replacing blood loss during these operations. Blood transfusion diagnostics are vital for screening and matching donor blood, thereby preventing transfusion-related infections and complications, which significantly enhances patient safety and clinical outcomes. For instance, data from June 2024, provided by the American Society of Plastic Surgeons, a US-based non-profit body, indicated a 7% increase in minimally invasive procedures in 2023, surpassing the growth rate of general surgical procedures by 2%. Furthermore, hand surgeries, including treatments for carpal tunnel, arthritis, and trigger finger, reached a total of 207,887 procedures, marking a 2% rise compared to 2022. Consequently, the increasing frequency of surgical procedures is a key driver for the growth of the blood transfusion diagnostics market.

    Blood Transfusion Diagnostics Market Segment Analysis: What Are The Core Market Categories?

    The blood transfusion diagnostics market covered in this report is segmented –

    1) By Type: Instruments And Kits, Reagents, Other Types

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test

    3) By Application: Blood Grouping, Disease Screening

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

    Subsegments:

    1) By Instruments And Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes And Other Reagents

    3) By Other Types: Software Solutions, Consumables, Training And Support Services

    #Blood Transfusion Diagnostics Market Growth Trends: What’s Shaping The Future Outlook?

    Leading companies in the blood transfusion diagnostics market are developing sophisticated technology, including advancements in transfusion methods, to boost the precision of blood typing, elevate patient safety, minimize the danger of transfusion-transmitted infections, and optimize the overall transfusion procedure. Innovations in transfusion technology encompass improvements and progress in the techniques, equipment, and processes utilized in blood transfusion. For example, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, introduced Omnys, a significant breakthrough in transfusion, grouping, and blood testing. This state-of-the-art diagnostic platform is built to deliver swift and precise blood typing, compatibility assessments, and pathogen identification. This innovative technology leverages advanced biomarker identification and automation to facilitate the transfusion process, guaranteeing the safe pairing of blood products with patients.

    Blood Transfusion Diagnostics Market Leading Players And Competitive Positioning

    Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.

    View The Full Blood Transfusion Diagnostics Market Report:

    https://thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

    Blood Transfusion Diagnostics Market Regional Distribution: Which Areas Power Market Growth?

    North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Blood Transfusion Diagnostics Market Projected To Surpass $6.86 Billion By 2030 At 6.4% CAGR

    Blood Transfusion Diagnostics Market Projected To Surpass $6.86 Billion By 2030 At 6.4% CAGR

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Are The Forecasted Market Size Figures For The Blood Transfusion Diagnostics Market In 2026 And 2030?

    The blood transfusion diagnostics market has experienced robust growth in recent years. It is projected to expand from $4.96 billion in 2025 to $5.35 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.9%. Historically, this market’s expansion can be linked to factors such as the limited availability of advanced blood diagnostics instruments, a prevalent reliance on manual blood grouping methods, an increase in hospital blood transfusion procedures, the rising incidence of transfusion-transmissible infections, and a scarcity of standardized reagents and kits.

    Significant expansion is anticipated for the blood transfusion diagnostics market in the coming years. Projections indicate its value will reach $6.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This growth throughout the forecast period stems from several factors, including the creation of high-throughput automated blood screening systems, a growing need for nucleic acid amplification and rapid testing, increased funding for blood banks and diagnostic laboratories, the integration of digital and AI-powered diagnostic solutions, and the broadening of plasma fractionation and research endeavors. Key trends shaping this period encompass an escalating demand for swift and precise blood typing, the wider acceptance of automated blood processing systems, an enlargement of disease screening functionalities, the expansion of plasma fractionation and diagnostic laboratories, and a heightened emphasis on standardization and quality control.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

    Which Core Factors Are Supporting The Expansion Of The Blood Transfusion Diagnostics Market?

    The blood transfusion diagnostics market is projected to expand due to the increasing volume of surgical procedures, which are medical interventions addressing injuries, diseases, or disorders. The rising global number of surgeries necessitates more safe and compatible blood transfusions to replenish blood lost. Blood transfusion diagnostics are vital for screening and matching donor blood, thereby preventing infections and complications and ensuring patient safety. For example, data from June 2024 by the American Society of Plastic Surgeons, a US-based non-profit, indicates that minimally invasive procedures grew by 7% in 2023, surpassing the growth of surgical procedures by 2%. Hand surgeries, including carpal tunnel, arthritis, and trigger finger, reached 207,887 procedures, marking a 2% increase from 2022. Consequently, the expanding number of surgical procedures is a key impetus for the blood transfusion diagnostics market. The increasing occurrence of blood-related diseases is anticipated to boost the expansion of the blood transfusion diagnostics market. These diseases include various conditions impacting blood composition, function, or production, such as anemias, leukemia, and clotting disorders. Blood transfusion diagnostics are crucial for the early identification and secure handling of these conditions, ensuring appropriate blood products and lowering the risk of patient complications. For example, in January 2023, the American Cancer Society Inc., a US-based professional organization, reported approximately 59,610 new cases of leukemia (all types) and 23,710 deaths from leukemia (all types). Additionally, about 20,380 new cases of acute myeloid leukemia (AML) were noted. Hence, the rising prevalence of blood-related diseases is a significant factor propelling the growth of the blood transfusion diagnostics market.

    How Is The Blood Transfusion Diagnostics Market Structured Across Different Market Segments?

    The blood transfusion diagnostics market covered in this report is segmented –

    1) By Type: Instruments And Kits, Reagents, Other Types

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test

    3) By Application: Blood Grouping, Disease Screening

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

    Subsegments:

    1) By Instruments And Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes And Other Reagents

    3) By Other Types: Software Solutions, Consumables, Training And Support Services

    What Trends Are Influencing The Blood Transfusion Diagnostics Market Outlook?

    Leading companies in the blood transfusion diagnostics market are developing advanced technologies, including innovations in transfusion technology, to improve the accuracy of blood typing, enhance patient safety, reduce the risk of transfusion-transmitted infections, and optimize the overall transfusion process. These innovations involve advancements and improvements in the methodologies, devices, and procedures employed in blood transfusion. For example, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, launched Omnys, a significant innovation for transfusion, grouping, and blood testing. This state-of-the-art diagnostic platform is designed to provide rapid and accurate blood typing, compatibility testing, and pathogen detection. The innovative technology utilizes advanced biomarker identification and automation to streamline the transfusion process, ensuring that blood products are safely matched to patients.

    Who Are The Companies Shaping The Blood Transfusion Diagnostics Market Landscape?

    Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.

    Access The Complete Blood Transfusion Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

    Which Region Holds The Largest Share In The Blood Transfusion Diagnostics Market?

    North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Customized Blood Transfusion Diagnostics Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp

    Browse Through More Reports Similar to the Global Blood Transfusion Diagnostics Market 2026, By The Business Research Company

    Blood Group Typing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

    Dialysis Devices And Equipment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dialysis-devices-and-equipment-global-market-report

    Hemodialysis And Peritoneal Dialysis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Growing Importance of Blood Transfusion Diagnostics in Surgical Procedures Driving the Blood Transfusion Diagnostics Market

    Growing Importance of Blood Transfusion Diagnostics in Surgical Procedures Driving the Blood Transfusion Diagnostics Market

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Is The Market Size Of The Blood Transfusion Diagnostics Market Expected To Change Between 2026 And 2030?

    The blood transfusion diagnostics market has experienced robust growth in recent years. This market is projected to expand from $4.96 billion in 2025 to $5.35 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.9%. The historical growth can be attributed to factors such as the limited availability of advanced blood diagnostics instruments, reliance on manual blood grouping methods, an increasing number of hospital blood transfusion procedures, the growing prevalence of transfusion-transmissible infections, and a lack of standardized reagents and kits.

    The blood transfusion diagnostics market size is anticipated to undergo significant growth in the upcoming years, with projections indicating it will reach $6.86 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. The expansion foreseen in this period stems from factors such as the advancement of high-throughput automated blood screening systems, increasing demand for nucleic acid amplification and rapid tests, growing investment in blood banks and diagnostic laboratories, the integration of digital and AI-enabled diagnostic solutions, and the broadening of plasma fractionation and research activities. Noteworthy trends for the forecast period include a rising demand for rapid and accurate blood typing, increased adoption of automated blood processing systems, an expansion of disease screening capabilities, growth in plasma fractionation and diagnostic laboratories, and an enhanced focus on standardization and quality control.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

    Which Economic Or Industry Drivers Are Impacting The Blood Transfusion Diagnostics Market?

    The projected expansion of the blood transfusion diagnostics market is significantly influenced by the increasing prevalence of surgical procedures. These procedures, encompassing medical operations to address injuries, illnesses, or conditions using manual or instrumental methods, necessitate safe and compatible blood transfusions to replenish blood loss. Consequently, the indispensable role of blood transfusion diagnostics in screening and matching donor blood to avert transfusion-related complications and infections, thereby enhancing patient safety and clinical results, becomes more pronounced. For instance, data from June 2024, provided by the American Society of Plastic Surgeons, a US-based non-profit organization, indicated a 7% increase in minimally invasive procedures in 2023, surpassing the overall growth of surgical procedures by 2%. Furthermore, hand surgeries, including those for carpal tunnel, arthritis, and trigger finger, reached a total of 207,887 procedures, representing a 2% increment from 2022. Thus, the escalating volume of surgical procedures is a primary catalyst for the growth of the blood transfusion diagnostics market.

    Blood Transfusion Diagnostics Market Driver: Rising Prevalence Of Blood-Related Diseases Fuels Blood Transfusion Diagnostics Market Growth

    How Is The Blood Transfusion Diagnostics Market Structured Across Different Segments?

    The blood transfusion diagnostics market covered in this report is segmented –

    1) By Type: Instruments And Kits, Reagents, Other Types

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test

    3) By Application: Blood Grouping, Disease Screening

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

    Subsegments:

    1) By Instruments And Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes And Other Reagents

    3) By Other Types: Software Solutions, Consumables, Training And Support Services

    Which Trends Are Shaping The Future Of The Blood Transfusion Diagnostics Market?

    Major companies in the blood transfusion diagnostics market are developing advanced technologies, such as novel transfusion methods, to improve the accuracy of blood typing, enhance patient safety, decrease the risk of transfusion-transmitted infections, and optimize the overall transfusion process. Innovations in transfusion technology refer to advancements and improvements in the techniques, devices, and procedures utilized in blood transfusion. For example, in June 2024, Innobiochips Co. Ltd., a biotechnology company from France, released Omnys, a significant innovation in transfusion, grouping, and blood testing. This is a cutting-edge diagnostic platform designed to offer quick and precise blood typing, compatibility testing, and pathogen detection. This pioneering technology employs advanced biomarker identification and automation to streamline the transfusion process, ensuring that blood products are safely matched to patients.

    Which Major Players Dominate The Blood Transfusion Diagnostics Market?

    Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.

    Read the full blood transfusion diagnostics market report here:

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

    What Are The Top-Performing Regions Within The Blood Transfusion Diagnostics Market?

    North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Blood Transfusion Diagnostics Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp

    Browse Through More Reports Similar to the Global Blood Transfusion Diagnostics Market 2026, By The Business Research Company

    Blood Group Typing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

    Dialysis Devices And Equipment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dialysis-devices-and-equipment-global-market-report

    Hemodialysis And Peritoneal Dialysis Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Blood Transfusion Diagnostics Global Forecast: Market to Scale Up to $6.86 Billion by 2030 at 6.4% CAGR

    Blood Transfusion Diagnostics Global Forecast: Market to Scale Up to $6.86 Billion by 2030 at 6.4% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the plate fin coil market from 2026–2035 with trusted insights from The Business Research Company

    By how much is the Blood Transfusion Diagnostics Market expected to grow between 2026 and 2030?

    The blood transfusion diagnostics market size has demonstrated significant expansion in recent years. This market is expected to increase from $4.96 billion in 2025 to $5.35 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.9%. The market’s past growth can be attributed to various factors, including the limited availability of advanced blood diagnostics instruments, a reliance on manual blood grouping methods, an increase in hospital blood transfusion procedures, the growing prevalence of transfusion-transmissible infections, and a lack of standardized reagents and kits.

    The blood transfusion diagnostics market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $6.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth is driven by several factors, including the advancement of high-throughput automated blood screening systems, a growing need for nucleic acid amplification and rapid diagnostic tests, increased capital expenditure in blood banks and diagnostic laboratories, the integration of digital and AI-powered diagnostic tools, and the expansion of both plasma fractionation and research endeavors. Key trends expected during this period involve a heightened requirement for swift and precise blood typing, the wider implementation of automated blood processing systems, an increase in disease screening capacities, the expansion of plasma fractionation and diagnostic facilities, and a stronger emphasis on standardization and quality assurance.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

    Which Drivers Are Influencing Market Acceleration In The Blood Transfusion Diagnostics Market?

    The increasing volume of surgical interventions is anticipated to propel the expansion of the blood transfusion diagnostics market. Surgical procedures involve medical operations conducted to address injuries, diseases, or disorders using manual or instrumental techniques. As the worldwide count of surgeries rises, there is a corresponding greater need for secure and compatible blood transfusions to replenish blood lost during these operations. Blood transfusion diagnostics play a vital role in screening and matching donor blood to prevent transfusion-related infections and complications, thereby ensuring patient safety and improving clinical outcomes. For instance, data from June 2024 by the American Society of Plastic Surgeons, a US-based non-profit organization, indicated that minimally invasive procedures saw a 7% increase in 2023, surpassing the growth rate of overall surgical procedures by 2%. Additionally, hand surgeries, covering conditions like carpal tunnel, arthritis, and trigger finger, reached a total of 207,887 procedures, marking a 2% rise from 2022. Consequently, the growing number of surgical procedures is acting as a key driver for the blood transfusion diagnostics market’s growth.

    Blood Transfusion Diagnostics Market Driver: Rising Prevalence Of Blood-Related Diseases Fuels Blood Transfusion Diagnostics Market Growth

    The escalating incidence of blood-related conditions is projected to boost the blood transfusion diagnostics market’s development. These diseases encompass a broad spectrum of disorders impacting the composition, function, or production of blood and its components, including various anemias, leukemia, and clotting disorders. Blood transfusion diagnostics are instrumental in the early detection and safe management of such conditions, guaranteeing compatible blood products and minimizing complication risks for patients. For example, in January 2023, figures from the American Cancer Society Inc., a US-based professional organization, reported approximately 59,610 new cases of leukemia (all types) and 23,710 deaths attributable to leukemia (all types). Moreover, around 20,380 new cases of acute myeloid leukemia (AML) were identified. Therefore, the expanding prevalence of blood-related diseases is a significant factor driving the growth of the blood transfusion diagnostics market.

    What Segments Are Identified Within The Structure Of The Blood Transfusion Diagnostics Market?

    The blood transfusion diagnostics market covered in this report is segmented –

    1) By Type: Instruments And Kits, Reagents, Other Types

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test

    3) By Application: Blood Grouping, Disease Screening

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

    Subsegments:

    1) By Instruments And Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes And Other Reagents

    3) By Other Types: Software Solutions, Consumables, Training And Support Services

    How Are New Market Trends Shaping The Landscape Of The Blood Transfusion Diagnostics Market?

    Leading companies in the blood transfusion diagnostics market are advancing technology, specifically innovations in transfusion technology, to improve the precision of blood typing, bolster patient safety, mitigate the threat of transfusion-transmitted infections, and enhance the efficiency of the overall transfusion process. Innovations in transfusion technology pertain to progress and enhancements in the techniques, tools, and procedures utilized in blood transfusion. As an illustration, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, introduced Omnys, a significant innovation in transfusion, grouping, and blood testing. This state-of-the-art diagnostic platform is engineered to deliver swift and accurate blood typing, compatibility assessments, and pathogen identification. The innovative technology harnesses advanced biomarker identification and automation to optimize the transfusion process, thereby ensuring that blood products are safely matched to patients.

    Which Key Players Are Driving Competition In The Blood Transfusion Diagnostics Market?

    Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

    Which Region Is Projected To Lead The Blood Transfusion Diagnostics Market During The Forecast Period?

    North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Blood Transfusion Diagnostics Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp

    Browse Through More Reports Similar to the Global Blood Transfusion Diagnostics Market 2026, By The Business Research Company

    Blood Group Typing Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

    Dialysis Devices And Equipment Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dialysis-devices-and-equipment-global-market-report

    Hemodialysis And Peritoneal Dialysis Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

  • Blood Transfusion Diagnostics Industry Growth Expected to Reach $6.43 Billion by 2029 at a CAGR of 6.7% | Segmentation and Growth Opportunities

    Blood Transfusion Diagnostics Industry Growth Expected to Reach $6.43 Billion by 2029 at a CAGR of 6.7% | Segmentation and Growth Opportunities

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #How Has the Blood Transfusion Diagnostics Market Growth Performance Trended Historically, And What Lies Ahead?

    The market size for blood transfusion diagnostics has experienced a swift expansion in the past few years. The market is projected to rise from $4.42 billion in 2024 to $4.96 billion in 2025, with a compound annual growth rate (CAGR) of 12.2%. Reasons for this growth during the historic period include an upsurge in blood transfusions, the advent of new pathogens, an aging demographic, escalated demand for fast blood transfusion diagnostics, a climbing prevalence of chronic illnesses, and an increased demand for blood.

    What Is the Forecast for the Blood Transfusion Diagnostics Market Size Through 2029?

    We are anticipating a robust surge in the blood transfusion diagnostics market over the upcoming years, estimating a valuation of $6.43 billion by 2029, upholding a compound annual growth rate (CAGR) of 6.7%. This growth within the predicted period is seen as a result of the increasing need for precision medicine, substantial investment in blood transfusion facilities, rising demand for molecular blood transfusions, and new emerging infectious diseases, coupled with concerns related to blood safety. The forecast period also foresees significant trends such as advancements in diagnostic procedures, point-of-care testing, implementation of automation and robotics, the application of nucleic acid testing (NAT), digital integration, extension of pathogen panels, and the advent of advanced testing technologies.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

    What are the Key Market Players in Blood Transfusion Diagnostics Market and How They’re Evolving?

    Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.

    What Are the Primary Growth Drivers in the Blood Transfusion Diagnostics Market?

    The requirement for blood transfusion arises in patients who are subjected to surgical operations due to the loss of blood in the process. The role of blood transfusion diagnostics is crucial as they are utilized during the procedures for blood screening before its transfusion to the patient, thereby preventing the spread of infectious diseases. An article from the US National Library of Medicine, National Institutes of Health, mentions about 310 million surgeries being performed yearly. As a consequence of this rise in surgical procedures, the necessity for blood transfusion diagnostics is predicted to escalate.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp

    What Are the Leading Segments in the Global Blood Transfusion Diagnostics Industry?

    The blood transfusion diagnostics market covered in this report is segmented –

    1) By Type: Instruments and Kits, Reagents, Other Types

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test

    3) By Application: Blood Grouping, Disease Screening

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

    Subsegments:

    1) By Instruments and Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes and Other Reagents

    3) By Other Types: Software Solutions, Consumables, Training And Support Services

    What Are the Key Market Trends in the Blood Transfusion Diagnostics Industry?

    The escalating need for sophisticated diagnostic methods, coupled with the rising incidence of infectious diseases caused by bacteria and viruses, is fuelling the preference for nucleic acid amplification testing (NAAT/NAT). This technique enhances blood safety and efficiency while speeding up the result time. NAT effectively identifies specific nucleic acids, viruses, or bacteria that serve as pathogens in blood, tissue, or urine. It is extremely sensitive and precise in amplifying targeted viral DNA regions, thereby enabling earlier detection in comparison to other standard procedures and reducing the infectious period. For example, a licensing agreement has been established between XCRP Diagnostic Inc. and Luminex Corporations for the Xtreme Chain Reaction Nucleic Acid Amplification Technology from XCRP. This deal grants Luminex exclusive rights to incorporate XCRP’s NAAT technology into its imminent molecular diagnostic portfolio.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

    What Is the Regional Outlook for the Blood Transfusion Diagnostics Market?

    The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2494

    This Report Delivers Insight On:

    1. How big is the blood transfusion diagnostics market, and how is it changing globally?

    2. Who are the major companies in the blood transfusion diagnostics market, and how are they performing?

    3. What are the key opportunities and risks in the blood transfusion diagnostics market right now?

    4. Which products or customer segments are growing the most in the blood transfusion diagnostics market?

    5. What factors are helping or slowing down the growth of the blood transfusion diagnostics market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Factors Fueling the Growth of the Blood Transfusion Diagnostics Market in 2025: Emerging Importance Of Blood Transfusion Diagnostics In The Surge Of Surgical Procedures

    Key Factors Fueling the Growth of the Blood Transfusion Diagnostics Market in 2025: Emerging Importance Of Blood Transfusion Diagnostics In The Surge Of Surgical Procedures

    Discover trends, market shifts, and competitive outlooks for the blood transfusion diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    #What Are the Projected Market Size and Growth Rates for the Blood Transfusion Diagnostics Market From 2025 To 2029?#_x000D_

    In past few years, there has been a swift expansion in the size of the blood transfusion diagnostics market. The market is expected to climb from $4.42 billion in 2024 to $4.96 billion in 2025, with a compound annual growth rate (CAGR) of 12.2%. Factors such as an increase in blood transfusions, the emergence of new pathogens, an aging population, a growing demand for speedy blood transfusion diagnostics, a higher prevalence of chronic diseases, and a surge in blood needs account for the observed growth in this historical duration._x000D_

    _x000D_

    Predictions suggest that the market size for blood transfusion diagnostics will experience significant growth in the upcoming years, reaching $6.43 billion in 2029 with an expected compound annual growth rate (CAGR) of 6.7%. This expected growth during the forecast period could be due to increased interest in precision medicine, more investment in blood transfusion infrastructure, a growing need for molecular blood transfusions, a rise in infectious diseases, and concerns regarding blood safety. The forecast period is also expected to see notable trends such as advancements in diagnostics, point-of-care testing, automation and robotics, nucleic acid testing (NAT), digital integration, broadened pathogen panels, and innovative testing technologies._x000D_

    _x000D_

    #Download a free sample to assess the report’s scope and structure:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp_x000D_

    _x000D_

    #What are the Fundamental Drivers and Innovations Shaping the Blood Transfusion Diagnostics Market?#_x000D_

    During surgical procedures, there’s often a necessity for blood transfusions to compensate for the blood lost in the process. This is where blood transfusion diagnostics come into play, ensuring that the blood is properly screened before being given to the patient, and thus preventing the rise of infectious diseases. A report published by the US National Library of Medicine, National Institutes of Health stated around 310 million surgeries are executed yearly. Such an increasing trend in medical procedures invariably leads to a higher demand for blood transfusion diagnostics._x000D_

    _x000D_

    #How Is the Blood Transfusion Diagnostics Market Segmented?#_x000D_

    The blood transfusion diagnostics market covered in this report is segmented –_x000D_

    _x000D_

    1) By Type: Instruments and Kits, Reagents, Other Types_x000D_

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test_x000D_

    3) By Application: Blood Grouping, Disease Screening_x000D_

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Instruments and Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems_x000D_

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes and Other Reagents_x000D_

    3) By Other Types: Software Solutions, Consumables, Training And Support Services_x000D_

    _x000D_

    #Request customized data on this market:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp_x000D_

    _x000D_

    #Which Regions Are Driving the Next Phase of the Blood Transfusion Diagnostics Market Growth?#_x000D_

    The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada._x000D_

    _x000D_

    #What Key Market Trends and Innovations Are Shaping the Future of the Blood Transfusion Diagnostics Industry?#_x000D_

    The increasing need for superior diagnostic procedures and the escalating occurrence of diseases caused by microorganisms such as bacteria and viruses heighten the preference for NAT (NAAT/NAT) to enhance blood safety, improve efficiency, and cut down the time taken to get results. NAT is a method that assists in spotting a particular nucleic acid, virus, or bacteria that performs as a pathogen in blood, tissue, or urine. NAT is notably sensitive and accurate for viral nucleic acids, amplifies the targeted viral DNA area, and enables earlier detection compared to other traditional techniques, thus shortening the period of infectious illnesses. For instance, XCRP Diagnostic Inc. and Luminex Corporations formed a licensing agreement involving XCR Diagnostic’s Xtreme Chain Reaction Nucleic Acid Amplification Technology. Through this agreement, Luminex obtained exclusive rights to employ XCR Diagnostic’s NAAT technology for its upcoming molecular diagnostic portfolio._x000D_

    _x000D_

    #View the full report here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report_x000D_

    _x000D_

    #How Is the Blood Transfusion Diagnostics Market Defined and What Are Its Core Parameters?#_x000D_

    Blood transfusion diagnostics are used to conduct tests before the transfusion of blood from donor-recipient such as blood grouping disease screening._x000D_

    _x000D_

    #Purchase the full report and get a swift delivery:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2494_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 3156230293_x000D_

    Asia +44 2071930708_x000D_

    Europe +44 2071930708_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Blood Transfusion Diagnostics Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

    Blood Transfusion Diagnostics Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    How Are Key Drivers Contributing to the Growth and Expansion of the Blood Transfusion Diagnostics Market?

    Blood transfusion diagnostics are becoming increasingly important as the number of surgeries rises. As reported by the US National Library of Medicine, approximately 310 million surgeries are performed annually. Blood transfusion diagnostics are crucial to ensuring that blood is safe for transfusion and prevents the spread of infectious diseases, driving demand for these diagnostic tools.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

    #What is the Projected CAGR for the Blood Transfusion Diagnostics Market Size from 2025 to 2034?

    The blood transfusion diagnostics market size has grown rapidly in recent years. It will grow from $4.42 billion in 2024 to $4.96 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. This growth is attributed to increasing blood transfusions, the emergence of new pathogens, an aging population, and higher demand for rapid diagnostics.

    The blood transfusion diagnostics market is projected to grow at a strong pace, reaching $6.43 billion by 2029 at a CAGR of 6.7%. This growth is supported by the rising demand for precision medicine, increased investment in blood transfusion infrastructure, the demand for molecular blood transfusions, emerging infectious diseases, and blood safety concerns. Significant trends include advancements in diagnostic technologies, point-of-care testing, automation, nucleic acid testing (NAT), digital integration, expanded pathogen panels, and advanced testing technologies.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2494

    What Are the Key Market Innovations in theBlood Transfusion Diagnostics Market Over the Coming Years?

    The nucleic acid amplification testing (NAAT/NAT) market is growing due to the rising demand for advanced diagnostics and increasing prevalence of infectious diseases. NAT is a method that detects specific DNA or RNA sequences of pathogens in blood, tissue, or urine samples. It offers high sensitivity and specificity and can detect infections earlier than traditional techniques. For example, XCRP Diagnostic Inc. and Luminex Corporation entered into a licensing deal, granting Luminex exclusive rights to use XCR Diagnostic’s Xtreme Chain Reaction NAAT technology in its future molecular diagnostics.

    Who Are the Leading Market Players Fueling Growth in the Blood Transfusion Diagnostics Market Trend?

    Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

    How is the Global Blood Transfusion Diagnostics Market Segemented?

    The blood transfusion diagnostics market covered in this report is segmented –

    1) By Type: Instruments and Kits, Reagents, Other Types

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test

    3) By Application: Blood Grouping, Disease Screening

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

    Subsegments:

    1) By Instruments and Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes and Other Reagents

    3) By Other Types: Software Solutions, Consumables, Training And Support Services

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp

    Which Geographics are Influencing the Growth of the Blood Transfusion Diagnostics Market?

    The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

    Browse Through More Reports Similar to the Global Blood Transfusion Diagnostics Market 2025, By The Business Research Company:

    Blood And Blood Components Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

    Blood Glucose Meters Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

    Hemodialysis And Peritoneal Dialysis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • In-Depth Insights into the Blood Transfusion Diagnostics Market: Growth, Trends, and Opportunities for 2025-2034

    In-Depth Insights into the Blood Transfusion Diagnostics Market: Growth, Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the blood transfusion diagnostics market grown in recent years?

    In the past few years, the blood transfusion diagnostics market has experienced a swift expansion. The market size, which stood at $4.42 billion in 2024, is predicted to reach $4.96 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. This significant growth during the historical period is primarily linked with factors such as the rise in blood transfusion procedures, the emergence of new pathogens, an aging population, an escalation in the need for quick blood transfusion diagnostics, an increased prevalence of chronic illnesses, and a heightened demand for blood.

    How is the blood transfusion diagnostics market size expected to evolve during the forecast period?

    In the coming years, the blood transfusion diagnostics market is projected to witness significant growth, escalating to a value of $6.43 billion by 2029, with a compound annual growth rate (CAGR) of 6.7%. This upward trajectory during the forecast period is largely due to an increased need for precision medicine, increased funds towards blood transfusion infrastructure, a rising demand for molecular blood transfusions, the emergence of infectious diseases, and concerns related to blood safety. Some major trends to look out for during this forecast period are advancements in diagnostics, point-of-care testing, automated systems and robotics, nucleic acid testing (NAT), digital integration, broader pathogen panels, and enhanced testing technologies.

    Get your blood transfusion diagnostics market report here!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

    Which key drivers are propelling the blood transfusion diagnostics market’s growth?

    Patients who are in the process of having surgical procedures often require blood transfusions to compensate for the blood loss that occurs during this process. Before the transfusion, blood transfusion diagnostics are utilized to screen the blood to prevent the spread of infectious diseases. The US National Library of Medicine and National Institutes of Health reveal in an article that around 310 million surgeries are conducted each year. As a result, the surge in the number of these procedures heightens the demand for blood transfusion diagnostics.

    What are the market segments in the blood transfusion diagnostics industry?

    The blood transfusion diagnostics market covered in this report is segmented –

    1) By Type: Instruments and Kits, Reagents, Other Types

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test

    3) By Application: Blood Grouping, Disease Screening

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

    Subsegments:

    1) By Instruments and Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes and Other Reagents

    3) By Other Types: Software Solutions, Consumables, Training And Support Services

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

    Which leading companies are shaping the growth of the blood transfusion diagnostics market?

    Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.

    What key trends are currently impacting the blood transfusion diagnostics market’s development?

    The rising necessity for sophisticated diagnostic measures and the increasing occurrence of infectious diseases related to pathogens like bacteria and viruses have propelled the preference for nucleic acid amplification testing (NAAT/NAT) as a means to enhance blood safety, increase efficiency, and reduce the time needed for results. NAT is a method that allows detection of a specific nucleic acid, virus, or bacteria that serves as a pathogen in blood, tissue, or urine. Possessing high sensitivity and specificity for viral nucleic acids, NAT amplifies the targeted viral DNA region, thereby detecting these earlier than traditional methods and shortening the duration of infectious diseases. Illustratively, XCRP Diagnostic Inc. and Luminex Corporations formed a licensing agreement for utilizing XCR Diagnostic’s Xtreme Chain Reaction Nucleic Acid Amplification Technology, granting Luminex exclusive rights to use XCR Diagnostic’s NAAT technology in its upcoming molecular diagnostic portfolio.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2494

    Which geographic areas are influencing the growth of the blood transfusion diagnostics market?

    North America was the largest region in the blood transfusion diagnostics market in 2024. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Blood And Blood Components Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

    Blood Glucose Meters Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

    Hemodialysis And Peritoneal Dialysis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Growth, Trends, and Opportunities in the Blood Transfusion Diagnostics Market: Key Insights for the Next Decade

    Growth, Trends, and Opportunities in the Blood Transfusion Diagnostics Market: Key Insights for the Next Decade

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Long-Term Projected Growth Rate for the Blood Transfusion Diagnostics Market, and What Are the Key Drivers?

    In the past few years, the blood transfusion diagnostics market has experienced a swift expansion. The market size, which stood at $4.42 billion in 2024, is predicted to reach $4.96 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. This significant growth during the historical period is primarily linked with factors such as the rise in blood transfusion procedures, the emergence of new pathogens, an aging population, an escalation in the need for quick blood transfusion diagnostics, an increased prevalence of chronic illnesses, and a heightened demand for blood.

    In the coming years, the blood transfusion diagnostics market is projected to witness significant growth, escalating to a value of $6.43 billion by 2029, with a compound annual growth rate (CAGR) of 6.7%. This upward trajectory during the forecast period is largely due to an increased need for precision medicine, increased funds towards blood transfusion infrastructure, a rising demand for molecular blood transfusions, the emergence of infectious diseases, and concerns related to blood safety. Some major trends to look out for during this forecast period are advancements in diagnostics, point-of-care testing, automated systems and robotics, nucleic acid testing (NAT), digital integration, broader pathogen panels, and enhanced testing technologies.

    Which Primary Drivers Are Supporting the Continued Expansion of the Blood Transfusion Diagnostics Market?

    Patients who are in the process of having surgical procedures often require blood transfusions to compensate for the blood loss that occurs during this process. Before the transfusion, blood transfusion diagnostics are utilized to screen the blood to prevent the spread of infectious diseases. The US National Library of Medicine and National Institutes of Health reveal in an article that around 310 million surgeries are conducted each year. As a result, the surge in the number of these procedures heightens the demand for blood transfusion diagnostics.

    Explore Comprehensive Insights Into The Global Blood Transfusion Diagnostics Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

    Which Companies Are Leading the Charge in Expanding the Blood Transfusion Diagnostics Market?

    Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.

    How Are Consumer Trends Shaping the Current and Future Landscape of the Blood Transfusion Diagnostics Market?

    The rising necessity for sophisticated diagnostic measures and the increasing occurrence of infectious diseases related to pathogens like bacteria and viruses have propelled the preference for nucleic acid amplification testing (NAAT/NAT) as a means to enhance blood safety, increase efficiency, and reduce the time needed for results. NAT is a method that allows detection of a specific nucleic acid, virus, or bacteria that serves as a pathogen in blood, tissue, or urine. Possessing high sensitivity and specificity for viral nucleic acids, NAT amplifies the targeted viral DNA region, thereby detecting these earlier than traditional methods and shortening the duration of infectious diseases. Illustratively, XCRP Diagnostic Inc. and Luminex Corporations formed a licensing agreement for utilizing XCR Diagnostic’s Xtreme Chain Reaction Nucleic Acid Amplification Technology, granting Luminex exclusive rights to use XCR Diagnostic’s NAAT technology in its upcoming molecular diagnostic portfolio.

    Secure Your Global Blood Transfusion Diagnostics Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

    What Are the Major Segments of the Blood Transfusion Diagnostics Market and Their Role in Driving Growth?

    The blood transfusion diagnostics market covered in this report is segmented –

    1) By Type: Instruments and Kits, Reagents, Other Types

    2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test

    3) By Application: Blood Grouping, Disease Screening

    4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

    Subsegments:

    1) By Instruments and Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

    2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes and Other Reagents

    3) By Other Types: Software Solutions, Consumables, Training And Support Services

    What Are the Top Regions Fueling Growth in the Blood Transfusion Diagnostics Market?

    The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

    How Is the Blood Transfusion Diagnostics Market Defined Across Different Regions?

    Blood transfusion diagnostics are used to conduct tests before the transfusion of blood from donor-recipient such as blood grouping disease screening.

    Browse Through More Similar Reports By The Business Research Company:

    Blood And Blood Components Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

    Blood Glucose Meters Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

    Hemodialysis And Peritoneal Dialysis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: